These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 19961757)
1. [Podoplanin expression in oral squamous cell carcinoma and leukoplakia and its correlation with lymph vessels density]. Zhang G; Guo ZL; Gao Y Zhonghua Kou Qiang Yi Xue Za Zhi; 2009 Aug; 44(8):488-91. PubMed ID: 19961757 [TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical Expression of Podoplanin in Clinical Variants of Oral Leukoplakia and Its Correlation With Epithelial Dysplasia. D'souza B; Nayak R; Kotrashetti VS Appl Immunohistochem Mol Morphol; 2018 Feb; 26(2):132-139. PubMed ID: 27153448 [TBL] [Abstract][Full Text] [Related]
3. Dual role of podoplanin in oral cancer development. Cîrligeriu L; Cimpean AM; Raica M; Doroş CI In Vivo; 2014; 28(3):341-7. PubMed ID: 24815836 [TBL] [Abstract][Full Text] [Related]
5. [Expression of Prion protein and its clinical significance in oral squamous cells carcinoma and oral leukoplakia]. Zhang J; Zeng Y; Zheng J; Xu J Zhonghua Kou Qiang Yi Xue Za Zhi; 2013 Dec; 48(12):752-4. PubMed ID: 24495728 [TBL] [Abstract][Full Text] [Related]
6. Podoplanin expression correlates with sentinel lymph node metastasis in early squamous cell carcinomas of the oral cavity and oropharynx. Huber GF; Fritzsche FR; Züllig L; Storz M; Graf N; Haerle SK; Jochum W; Stoeckli SJ; Moch H Int J Cancer; 2011 Sep; 129(6):1404-9. PubMed ID: 21105028 [TBL] [Abstract][Full Text] [Related]
7. The immunohistochemical characterization of MMP-2, MMP-10, TIMP-1, TIMP-2, and podoplanin in oral squamous cell carcinoma. Mashhadiabbas F; Mahjour F; Mahjour SB; Fereidooni F; Hosseini FS Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Aug; 114(2):240-50. PubMed ID: 22769410 [TBL] [Abstract][Full Text] [Related]
8. [Expression of integrin-linked kinase in oral leukoplakia and early invasive carcinoma]. Guo ZL; Gao Y Zhonghua Kou Qiang Yi Xue Za Zhi; 2010 Mar; 45(3):163-7. PubMed ID: 20450685 [TBL] [Abstract][Full Text] [Related]
9. Lymphangiogenesis and podoplanin expression in oral squamous cell carcinoma and the associated lymph nodes. de Sousa SF; Gleber-Netto FO; de Oliveira-Neto HH; Batista AC; Nogueira Guimarães Abreu MH; de Aguiar MC Appl Immunohistochem Mol Morphol; 2012 Dec; 20(6):588-94. PubMed ID: 22495364 [TBL] [Abstract][Full Text] [Related]
10. Podoplanin expression in tumor-free resection margins of oral squamous cell carcinomas: an immunohistochemical and fractal analysis study. Margaritescu C; Raica M; Pirici D; Simionescu C; Mogoanta L; Stinga AC; Stinga AS; Ribatti D Histol Histopathol; 2010 Jun; 25(6):701-11. PubMed ID: 20376776 [TBL] [Abstract][Full Text] [Related]
11. [The expression of urokinase-type plasminogen activator in oral squamous cell carcinoma]. Liang X; Mao Z; He Y Hua Xi Kou Qiang Yi Xue Za Zhi; 2003 Apr; 21(2):147-9. PubMed ID: 12838705 [TBL] [Abstract][Full Text] [Related]
12. Enhanced expression of podoplanin in oral carcinomas in situ and squamous cell carcinomas. Funayama A; Cheng J; Maruyama S; Yamazaki M; Kobayashi T; Syafriadi M; Kundu S; Shingaki S; Saito C; Saku T Pathobiology; 2011; 78(3):171-80. PubMed ID: 21613804 [TBL] [Abstract][Full Text] [Related]
13. E-cadherin as a potential biomarker of malignant transformation in oral leukoplakia: a retrospective cohort study. von Zeidler SV; de Souza Botelho T; Mendonça EF; Batista AC BMC Cancer; 2014 Dec; 14():972. PubMed ID: 25518919 [TBL] [Abstract][Full Text] [Related]
14. Intratumoral c-Met expression is associated with vascular endothelial growth factor C expression, lymphangiogenesis, and lymph node metastasis in oral squamous cell carcinoma: implications for use as a prognostic marker. Zhao D; Wang SH; Feng Y; Hua CG; Zhao J; Tang XF Hum Pathol; 2011 Oct; 42(10):1514-23. PubMed ID: 21531000 [TBL] [Abstract][Full Text] [Related]
15. Tumor cell expression of podoplanin correlates with nodal metastasis in esophageal squamous cell carcinoma. Chuang WY; Yeh CJ; Wu YC; Chao YK; Liu YH; Tseng CK; Chang HK; Liu HP; Hsueh C Histol Histopathol; 2009 Aug; 24(8):1021-7. PubMed ID: 19554509 [TBL] [Abstract][Full Text] [Related]
16. Positive and negative regulation of podoplanin expression by TGF-β and histone deacetylase inhibitors in oral and pharyngeal squamous cell carcinoma cell lines. Ohta M; Abe A; Ohno F; Hasegawa Y; Tanaka H; Maseki S; Kondo E; Kurita K; Nakanishi H Oral Oncol; 2013 Jan; 49(1):20-6. PubMed ID: 22840788 [TBL] [Abstract][Full Text] [Related]
17. Role of podoplanin expression in esophageal squamous cell carcinoma: a retrospective study. Tong L; Yuan S; Feng F; Zhang H Dis Esophagus; 2012 Jan; 25(1):72-80. PubMed ID: 21895849 [TBL] [Abstract][Full Text] [Related]
18. Correlation between podoplanin expression and extracapsular spread in squamous cell carcinoma of the oral cavity using subjective immunoreactivity scores and semiquantitative image analysis. Mermod M; Bongiovanni M; Petrova TV; Dubikovskaya EA; Simon C; Tolstonog G; Monnier Y Head Neck; 2017 Jan; 39(1):98-108. PubMed ID: 27437903 [TBL] [Abstract][Full Text] [Related]
19. Osteopontin: a marker for invasive oral squamous cell carcinoma but not for potentially malignant epithelial dysplasias. Routray S; Kheur SM; Kheur M Ann Diagn Pathol; 2013 Oct; 17(5):421-4. PubMed ID: 23711950 [TBL] [Abstract][Full Text] [Related]